| CAS: | 52-49-3 | |||||||||||||||||||||||||
| 分子式: | C20H32ClNO | |||||||||||||||||||||||||
| 分子量: | 337.93 | |||||||||||||||||||||||||
| 中文名称: |
| |||||||||||||||||||||||||
| 英文名称: |
| |||||||||||||||||||||||||
| 用途: | 老年震颤。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||||||
| T797272 | MACKLIN | 盐酸苯海索 | 10mM in DMSO | 620元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C 状态:液体 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| T857974 | MACKLIN | 盐酸苯海索 | ≥98% | 62元/1g; 220元/5g; 693元/25g; 1800元/100g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
储存:室温,干燥 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| T3303 | TCI | Trihexyphenidyl Hydrochloride | >98.0%(T)(HPLC) | 490元/5G; 1640元/25G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| 553649 | J&K | Trihexyphenidyl Hydrochloride | 98%, 是抗毒蕈碱类的抗帕金森剂, 与M1毒蕈碱受体相结合 | 124元/1G; 494元/5G; 1415元/25G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 Trihexyphenidyl hydrochloride是一种抗毒蕈碱类的抗帕金森病药物。 靶点(IC50 & Targe) AChR 体内研究 在MWM试验的前3个月,经Trihexyphenidyl(THP)处理的大鼠平均潜伏期明显延长,4-6月时,行为缺陷被修复。被THP显著下调的基因是与免疫反应、抗原加工和递呈、主要组织相容性复合体相关的基因。在老化的大脑中,THP的处理降低MHC class I的表达,长期处理THP使大鼠额叶皮层运动区的海马和皮质小神经胶质发生炎性表型的转变、结构变化[2]。 动物实验 Animal Models: Male Sprague-Dawley rats (SD) Formulation: 生理盐水 Dosages: 0.3 and 1.0 mg/kg Administration: 腹膜腔内注射 (Only for Reference) 参考文献 [1] Huang Y, et al. J Neuroinflammation. 2016, 13(1):175. [2] Amal M. Moustafa, et al. The Egyptian Journal of Histology. 2 安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0000108 | Trihexyphenidyl Hydrochloride | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| 1687006 | USP | Trihexyphenidyl Hydrochloride | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| BP034 | Trihexyphenidyl Hydrochloride | British Pharmacopoeia (BP) Reference Standard | 466.22元/100 MG; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||